Organisms | Evidence |
---|---|
Sus scrofa (pig) | |
unidentified influenza virus | |
Saccharomyces cerevisiae (brewer's yeast) |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT1 | UDP-Gal |
|
R |
|
R | |
B3GALT5 | UDP-Gal |
|
R |
|
R |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B4GALT3 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT4 | UDP-Gal |
|
[beta]-1-Benzl |
|
[beta]-1-Benzl | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl |
Pathway Name | Organism |
---|---|
Antimicrobial peptides | Drosophila melanogaster |
Antimicrobial peptides | Rattus norvegicus |
Antimicrobial peptides | Danio rerio |
Antimicrobial peptides | Xenopus tropicalis |
Antimicrobial peptides | Gallus gallus |
Antimicrobial peptides | Homo sapiens |
Antimicrobial peptides | Canis familiaris |
Antimicrobial peptides | Dictyostelium discoideum |
Antimicrobial peptides | Bos taurus |
Antimicrobial peptides | Mus musculus |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
37443315 | Cryo-EM Structures of Full-length Integrin alphaIIbbeta3 in Native Lipids complexed with Eptifibatide | Adair B | 2023 Jul 26 |
|
37453062 | Systematic analysis of the impact of phosphorylation and O-GlcNAcylation on protein subcellular localization | Xu S | 2023 Jul 25 |
|
37474494 | A maize epimerase modulates cell wall synthesis and glycosylation during stomatal morphogenesis | Zhou Y | 2023 Jul 20 |
|
37471688 | C-2 Thiophenyl Tryptophan Trimers Inhibit Cellular Entry of SARS-CoV-2 through Interaction with the Viral Spike (S) Protein | Gargantilla M | 2023 Jul 20 |
|
37468498 | A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs | Sutherland JJ | 2023 Jul 19 |
|
37463923 | Conformational trajectory of allosteric gating of the human cone photoreceptor cyclic nucleotide-gated channel | Hu Z | 2023 Jul 18 |
|
37169147 | d-Glucosamine induces circadian phase delay by promoting BMAL1 degradation through AMPK/mTOR pathway | Li Z | 2023 Jul 15 |
|
37452031 | Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants | Moriyama S | 2023 Jul 14 |
|
37428845 | 3D structures of the Plasmodium vivax subtilisin-like drug target SUB1 reveal conformational changes to accommodate a substrate-derived α-ketoamide inhibitor | Martinez M | 2023 Jul 10 |
|
37279852 | O-GlcNAcylation in cancer development and immunotherapy | He XF | 2023 Jul 10 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025